The rapid spread of SARS-CoV-2 has heavily impacted global society with high pressure of COVID-19 on public health and economics. MolGen is very proud to have assisted in relieving some of the pressure and support the testing framework. Our high-quality nucleic acid extraction kits provide laboratories worldwide with innovative solution for efficient high throughput testing possibilities...
Software which helps speed up the process of creating new diagnostic tests could help combat future pandemics, its developers say. A team of bioengineers and chemists in Scotland and China have developed a system which suggests new reaction pathways to accelerate the design and development of new diagnostic assays. The system, which is now freely available for other researchers around the world to investigate, adapt and use, can also be used to identify the early stages of non-infectious diseases...
TestRAMP, the UK marketplace for Covid-19 PCR testing, is launching a new service for genomic testing and profiling of other diseases. Mike Hudson, CEO, said “We want to put the experience of working with the UK’s top genetic and genomic laboratories to good use. Covid testing grew the capacity and expertise of PCR and genomic sequencing labs – now they are well placed to offer molecular testing for other serious diseases”...
Biotool Switzerland has added a new version of its TubeFiller automated bottle / tube filling system to their range of easy-to-use, productivity enhancing sample handling and sample preparation equipment. The TubeFiller TF 3000x is a versatile system proven to deliver true walkaway filling of tubes, well plates or bottles in any standard rack format. The TubeFiller is not only versatile but is the only automated filling instrument on the market capable of filling up to 2000 tubes or bottles per hour with good reproducibility, making it perfect for COVID-19 testing labs...
The surge in demand brought about by COVID-19 is pushing medical and non-medical laboratories to their limits, the head of a laboratory supplies company has said, with concerns that clinical laboratories have been favoured due to the pandemic. The Starlab Group, a European supplier of laboratory products with a UK division, conducted a survey of more than 200 laboratory employees from the UK, Germany, Austria, Italy and France...
FOx BIOSYSTEMS, a company on the mission to revolutionize life science and pharmacological research with innovative real-time, analysis products and the Biosensors research group at KU Leuven, focused on developing innovative bio-molecular detection concepts and miniaturized analysis systems, announced a novel, label-free assay that can characterize the polyclonal antibody response against SARS-CoV-2 directly in patient blood...
AMSBIO has introduced further essential tools for SARS-CoV-2 researchers to help decipher the COVID-19 B.1.1.529 variant. New to the AMSBIO range are recombinant proteins, easy-to-perform assay kits, Omicron pseudotyped lentiviruses and spike neutralizing antibodies for use in functional assays to block SARS-CoV-2 spike protein and ACE2 binding...
AMSBIO announce the addition of several new products to its growing range of magnetic bead based nucleic acid extraction kits for pathogens detection. The MagSi-NA Pathogens MSP (Multiple Sample Pooling) kit sets a new benchmark for automated isolation of nucleic acids (RNA and DNA) from respiratory samples. Sample pooling is useful in times of high testing and low infection prevalence where traditional sample screening methods are not cost-effective....
AES Clean Technology, a leading provider of high-performance cleanroom facilities within the pharmaceutical and bio-pharmaceutical industry, has announced a $14.2 million investment to open a new manufacturing facility located in Manheim Borough, Lancaster County, Pennsylvania. The new state-of-the-art facility will see 97 full-time jobs created and will serve as a manufacturing hub for its modular cleanroom systems....
“Automation and industrialization of COVID-19 PCR-testing will facilitate an immense scale-up of the global PCR-testing capacity. It will allow for a new approach to keep society open: preventive, regular testing (twice per week), which will create green bubbles and get us ahead of the curve” - Niels Kruize, CCO, MolGen. To get ahead of the curve, we will need to change our methodology of COVID-19 testing...
OxDX, a University of Oxford spin out building instant pathogen tests using super-resolution microscopy and machine learning,has raised £2.6m in pre-seed funding for its AI powered diagnostic technology that can recognise and identify specific species and strains of viruses1,2, bacteria and other pathogens within a sample in seconds. The initial funding is co-led by IQ Capital and Ahren Innovation Capital with participation from Science Creates Ventures, and will be used to expand the team and further validate the technology with development partners...
Agilent Technologies Inc. announce that researchers from the QIMR Berghofer Medical Research Institute in Brisbane, Australia, collaborated with Agilent experts on a proof-of-concept FTIR-based saliva COVID-19 testing workflow using the Agilent Cary 630 FTIR Spectrometer. The study investigated the pathophysiological response to a COVID-19 infection through ATR-FTIR spectroscopy....
The startup company Novel Concepts Medical is delighted to announce another major breakthrough in its research of COVID-19. Its novel plant-based treatment has resulted in successfully inhibiting the COVID-19 Omicron variant and blocking its connection to human cells. In case studies, volunteers had negative PCR results within 48 hours and quickly recovered from more than 16 symptoms of long COVID-19, including memory loss, loss of taste and smell, headaches, fatigue, and many symptoms that are common to both COVID-19 and the flu...
Ziath reports on the widespread adoption of its DataPaq™ Cube rack reader in Covid-19 testing labs for tracking of sample tubes cryogenically stored in cryoboxes. Keeping track of large numbers of Covid-19 RNA extraction samples can be an onerous task. Many labs around the world are using 2ml screw cap tubes with 2D-barcodes on the base for this work, including those laboratories equipped through the successful UN/IAEA supply program....
Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, has demonstrated that its Optimer to the S1 subunit of SARS-CoV-2 Spike protein is able to detect the Omicron variant. In vitro analysis by Aptamer Group, has shown that the Optimer binder interacts with the Omicron Spike protein with affinity in the low nanomolar (nM) range, a characteristic known to drive sensitivity within diagnostic assays...
QIAGEN has announced it is working with genetic laboratories around the world to increase COVID-19 testing capacity with its artus® SARS-CoV-2 Prep&Amp UM Kit that uses liquid-based sample-preparation technology to cut processing times for PCR results by up to two thirds. The company has significantly expanded production capacities to be able to meet the growing testing demand spurred by the emergence of the new Omicron variant...
In Libya, the Deutsche Gesellschaft für internationale Zusammenarbeit GmbH (GIZ) has installed laboratory containers from Waldner, which were completely planned and designed in Wangen im Allgäu, Southern Germany. These laboratory capacities are intended to increase the accessibility of PCR tests in the region. On behalf of the German government, GIZ supports developing and emerging countries in the fight against corona...
Vaccines against the SARS-CoV-2 virus have been made possible by an unprecedented worldwide partnership. But medications against Covid-19 have as yet seen only partial success. With the support of the Bavarian Research Foundation, a Munich research team has developed a protein which has reliably prevented infection by the virus and its variants in cell culture tests...
AMSBIO has announced new additions to its portfolio of tools for COVID-19 research - two monoclonal antibodies that recognize the Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2. The human ACE2 receptor is found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Research has shown that ACE2 mediates COVID-19 infection through direct binding of the SARS-CoV-2 Spike protein....
Evotec SE has announced that the Company has been selected by the German Federal Ministry of Education and Research ("BMBF") to receive a grant for the development of EVT075, a potential first-in-class immunomodulatory therapy against COVID-19. Evotec is one of three companies receiving a highly competitive grant as part of a new initiative by the BMBF to support the clinical development of novel therapeutic candidates against COVID-19...
Ziath reports how its super-fast 2D barcode rack readers are assisting leading COVID-19 testing lab – SummerBio LLC (Menlo Park, California, USA) to offer rapid, low-cost, high-volume testing solutions for educational organizations, employers and laboratories. SummerBio was conceived during the early stages of the COVID-19 pandemic in the USA, to combat expense and slow turnaround times of existing PCR testing...
Novel Concepts Medical, founded by Rachel Alkalay, PhD, and based in Tel Aviv, is delighted to announce the successful testing of its plant-based formulations for the treatment of SARS-CoV-2, the virus responsible for the COVID-19 pandemic. The testing methodology was devised by Dr. Alkalay, who is the inventor of these formulations. The testing, led by Tracey Campbell, PhD, was carried out by the Centre for Microbial Chemical Biology at the Michael G. DeGroote Institute for Infectious Disease Research at McMaster University...
The rapid spread of SARS-CoV-2 has heavily impacted global society with high pressure of COVID-19 on public health and economics. MolGen is very proud to have assisted in relieving some of the pressure and support the testing framework. Our high-quality nucleic acid extraction kits provide laboratories worldwide with innovative solution for efficient high throughput testing possibilities...
Software which helps speed up the process of creating new diagnostic tests could help combat future pandemics, its developers say. A team of bioengineers and chemists in Scotland and China have developed a system which suggests new reaction pathways to accelerate the design and development of new diagnostic assays. The system, which is now freely available for other researchers around the world to investigate, adapt and use, can also be used to identify the early stages of non-infectious diseases...
TestRAMP, the UK marketplace for Covid-19 PCR testing, is launching a new service for genomic testing and profiling of other diseases. Mike Hudson, CEO, said “We want to put the experience of working with the UK’s top genetic and genomic laboratories to good use. Covid testing grew the capacity and expertise of PCR and genomic sequencing labs – now they are well placed to offer molecular testing for other serious diseases”...
Biotool Switzerland has added a new version of its TubeFiller automated bottle / tube filling system to their range of easy-to-use, productivity enhancing sample handling and sample preparation equipment. The TubeFiller TF 3000x is a versatile system proven to deliver true walkaway filling of tubes, well plates or bottles in any standard rack format. The TubeFiller is not only versatile but is the only automated filling instrument on the market capable of filling up to 2000 tubes or bottles per hour with good reproducibility, making it perfect for COVID-19 testing labs...
The surge in demand brought about by COVID-19 is pushing medical and non-medical laboratories to their limits, the head of a laboratory supplies company has said, with concerns that clinical laboratories have been favoured due to the pandemic. The Starlab Group, a European supplier of laboratory products with a UK division, conducted a survey of more than 200 laboratory employees from the UK, Germany, Austria, Italy and France...
FOx BIOSYSTEMS, a company on the mission to revolutionize life science and pharmacological research with innovative real-time, analysis products and the Biosensors research group at KU Leuven, focused on developing innovative bio-molecular detection concepts and miniaturized analysis systems, announced a novel, label-free assay that can characterize the polyclonal antibody response against SARS-CoV-2 directly in patient blood...
AMSBIO has introduced further essential tools for SARS-CoV-2 researchers to help decipher the COVID-19 B.1.1.529 variant. New to the AMSBIO range are recombinant proteins, easy-to-perform assay kits, Omicron pseudotyped lentiviruses and spike neutralizing antibodies for use in functional assays to block SARS-CoV-2 spike protein and ACE2 binding...
AMSBIO announce the addition of several new products to its growing range of magnetic bead based nucleic acid extraction kits for pathogens detection. The MagSi-NA Pathogens MSP (Multiple Sample Pooling) kit sets a new benchmark for automated isolation of nucleic acids (RNA and DNA) from respiratory samples. Sample pooling is useful in times of high testing and low infection prevalence where traditional sample screening methods are not cost-effective....
AES Clean Technology, a leading provider of high-performance cleanroom facilities within the pharmaceutical and bio-pharmaceutical industry, has announced a $14.2 million investment to open a new manufacturing facility located in Manheim Borough, Lancaster County, Pennsylvania. The new state-of-the-art facility will see 97 full-time jobs created and will serve as a manufacturing hub for its modular cleanroom systems....
“Automation and industrialization of COVID-19 PCR-testing will facilitate an immense scale-up of the global PCR-testing capacity. It will allow for a new approach to keep society open: preventive, regular testing (twice per week), which will create green bubbles and get us ahead of the curve” - Niels Kruize, CCO, MolGen. To get ahead of the curve, we will need to change our methodology of COVID-19 testing...
OxDX, a University of Oxford spin out building instant pathogen tests using super-resolution microscopy and machine learning,has raised £2.6m in pre-seed funding for its AI powered diagnostic technology that can recognise and identify specific species and strains of viruses1,2, bacteria and other pathogens within a sample in seconds. The initial funding is co-led by IQ Capital and Ahren Innovation Capital with participation from Science Creates Ventures, and will be used to expand the team and further validate the technology with development partners...
Agilent Technologies Inc. announce that researchers from the QIMR Berghofer Medical Research Institute in Brisbane, Australia, collaborated with Agilent experts on a proof-of-concept FTIR-based saliva COVID-19 testing workflow using the Agilent Cary 630 FTIR Spectrometer. The study investigated the pathophysiological response to a COVID-19 infection through ATR-FTIR spectroscopy....
The startup company Novel Concepts Medical is delighted to announce another major breakthrough in its research of COVID-19. Its novel plant-based treatment has resulted in successfully inhibiting the COVID-19 Omicron variant and blocking its connection to human cells. In case studies, volunteers had negative PCR results within 48 hours and quickly recovered from more than 16 symptoms of long COVID-19, including memory loss, loss of taste and smell, headaches, fatigue, and many symptoms that are common to both COVID-19 and the flu...
Ziath reports on the widespread adoption of its DataPaq™ Cube rack reader in Covid-19 testing labs for tracking of sample tubes cryogenically stored in cryoboxes. Keeping track of large numbers of Covid-19 RNA extraction samples can be an onerous task. Many labs around the world are using 2ml screw cap tubes with 2D-barcodes on the base for this work, including those laboratories equipped through the successful UN/IAEA supply program....
Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, has demonstrated that its Optimer to the S1 subunit of SARS-CoV-2 Spike protein is able to detect the Omicron variant. In vitro analysis by Aptamer Group, has shown that the Optimer binder interacts with the Omicron Spike protein with affinity in the low nanomolar (nM) range, a characteristic known to drive sensitivity within diagnostic assays...
QIAGEN has announced it is working with genetic laboratories around the world to increase COVID-19 testing capacity with its artus® SARS-CoV-2 Prep&Amp UM Kit that uses liquid-based sample-preparation technology to cut processing times for PCR results by up to two thirds. The company has significantly expanded production capacities to be able to meet the growing testing demand spurred by the emergence of the new Omicron variant...
In Libya, the Deutsche Gesellschaft für internationale Zusammenarbeit GmbH (GIZ) has installed laboratory containers from Waldner, which were completely planned and designed in Wangen im Allgäu, Southern Germany. These laboratory capacities are intended to increase the accessibility of PCR tests in the region. On behalf of the German government, GIZ supports developing and emerging countries in the fight against corona...
Vaccines against the SARS-CoV-2 virus have been made possible by an unprecedented worldwide partnership. But medications against Covid-19 have as yet seen only partial success. With the support of the Bavarian Research Foundation, a Munich research team has developed a protein which has reliably prevented infection by the virus and its variants in cell culture tests...
AMSBIO has announced new additions to its portfolio of tools for COVID-19 research - two monoclonal antibodies that recognize the Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2. The human ACE2 receptor is found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Research has shown that ACE2 mediates COVID-19 infection through direct binding of the SARS-CoV-2 Spike protein....
Evotec SE has announced that the Company has been selected by the German Federal Ministry of Education and Research ("BMBF") to receive a grant for the development of EVT075, a potential first-in-class immunomodulatory therapy against COVID-19. Evotec is one of three companies receiving a highly competitive grant as part of a new initiative by the BMBF to support the clinical development of novel therapeutic candidates against COVID-19...
Ziath reports how its super-fast 2D barcode rack readers are assisting leading COVID-19 testing lab – SummerBio LLC (Menlo Park, California, USA) to offer rapid, low-cost, high-volume testing solutions for educational organizations, employers and laboratories. SummerBio was conceived during the early stages of the COVID-19 pandemic in the USA, to combat expense and slow turnaround times of existing PCR testing...
Novel Concepts Medical, founded by Rachel Alkalay, PhD, and based in Tel Aviv, is delighted to announce the successful testing of its plant-based formulations for the treatment of SARS-CoV-2, the virus responsible for the COVID-19 pandemic. The testing methodology was devised by Dr. Alkalay, who is the inventor of these formulations. The testing, led by Tracey Campbell, PhD, was carried out by the Centre for Microbial Chemical Biology at the Michael G. DeGroote Institute for Infectious Disease Research at McMaster University...